Skip to main content
LLY
NYSE Life Sciences

Lilly Pays $1.5B Cash for Private Biotech Calytrix Bio

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1,455.36
Mkt Cap
$1.358T
52W Low
$850.51
52W High
$1,460
52W Position info
71% above low
Off High info
at 52W high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

LLY sits 71% above its 52-week low of $850.51.

Summary

Lilly agreed to buy privately held Calytrix Bio for $1.5 billion in cash, adding another bolt-on to a pipeline buildout that already includes the Merida Biosciences deal announced in late August. Calytrix shareholders receive an upfront cash payment plus clinical and regulatory milestone payments, and the company's lead biparatopic antibody targets mutant calreticulin-driven essential thrombocythemia and myelofibrosis. The price is small next to Lilly's scale and its recent $4.2 billion of acquired IPR&D charges from the AtaiBeckley and Curevo deals, so this is a modest, incremental spend rather than a thesis-changing bet. Lilly is trading near its 52-week high after a 39% revenue jump in Q3, and management has been steadily buying pipeline assets with cash flow from Mounjaro and Zepbound.

Updated with a Benzinga report · What changed

Updates

  1. · Benzinga — Calytrix shareholders receive an upfront cash payment plus clinical and regulatory milestone payments; Calytrix's lead biparatopic antibody targets mutant calreticulin-driven essential thrombocythemia and myelofibrosis.

At the time of this announcement, LLY was trading at $1,455.36 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.4T. The 52-week trading range was $850.51 to $1,460.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 12, 2026, 8:30 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $1,452.70
Real-time Price: $1,432.85 info
Change: -$19.85 (-1%) info
Market Cap: $1.347T info
LLY
Nov 12, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $1,447.85
Real-time Price: $1,432.85 info
Change: -$15.00 (-1%) info
Market Cap: $1.347T info
LLY
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,411.12
Real-time Price: $1,432.85 info
Change: +$21.73 (+2%) info
Market Cap: $1.347T info
LLY
Nov 09, 2026, 10:23 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1,394.15
Real-time Price: $1,432.85 info
Change: +$38.70 (+3%) info
Market Cap: $1.347T info
LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,432.85 info
Change: +$86.85 (+6%) info
Market Cap: $1.347T info